Hisense Bio

About:

Hisense Bio offers treatment for intractable dental diseases using physiological and periodontal ligament regeneration technology.

Website: http://hysensbio.com

Top Investors: KOREA INVESTMENT & SECURITIES, Korea Investment Partners, Timepolio Asset Management, KTB Network, DS Asset Management

Description:

Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.

Total Funding Amount:

22B KRW

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seongnam, Kyonggi-do, South Korea

Founded Date:

2016-01-01

Contact Email:

contact(AT)hysensbio.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2021-05-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai